chartexchange

ERAS
Erasca, Inc. Common Stock
stockNASDAQ

At CloseNov 18, 2026 3:59:58 PM EST
13.77USD-0.828%(-0.12)8,941,557
Pre-marketNov 18, 2026 9:25:30 AM EST
14.05USD+1.152%(+0.16)
After-hoursNov 18, 2026 4:42:30 PM EST
13.96USD+1.343%(+0.18)
Loading…
Loading…
Healthcare
Biotechnology
HQ
San Diego, CA, USA
Previous Close
$13.89
Beta
1.74
52-Week High
$24.28 2026-04-23
52-Week Low
$2.71 2025-11-18
SMA 50
$14.89
SMA 200
$15.30
Avg. Vol 10D
6.68M
Avg. Vol 30D
5.53M
Avg. Vol 90D
4.74M
Relative Vol
1.62
350.96M
256.41M
37,156,627
0.4100%
6,000,000
351
ERAS Profile

our mission at erasca is embedded in our name: to erase cancer in patients by creating a new generation of oncology drugs that we hope will not just treat, but actually cure. energized by recent scientific discoveries and advances in drugging various biological drivers of cancer, we are committed to solving oncology's hardest problems. we have assembled a proven team and joined forces with world-class collaborators who embrace our ambitious goals.

ERAS Performance
PeriodPriceDateChangeBeta
1W16.802026-11-11-17.98%0.343
1M13.622026-10-19+1.18%3.017
3M18.102026-08-18-23.87%2.687
6M10.272026-05-18+34.18%2.398
1Y2.862025-11-18+381.82%1.737
2Y2.732024-11-18+404.76%—
5Y18.222021-11-18-24.37%1.458
ERAS Stock Summary

Erasca, Inc. Common Stock (NASDAQ:ERAS) stock price today is $13.78, and today's volume is 8,941,557. ERAS is down 0.792% today. The 30 day average volume is 5.53M. ERAS market cap is $4.84B with 350.96M shares outstanding.